Publications

Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey.

MOGASALE, VV; Sinha, A; John, J; Hasan Farooqui, H; Ray, A; Chantler, T; Mogasale, V; Dhoubhadel, BG; EDMUNDS, WJ; Clark, A; ABBAS, K;

2024

BMJ public health, (2024).2 2 10.1136/bmjph-2024-001089.

Corrigendum to "Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in Argentina" [Vaccine. Volume 42, Issue 23, 3 October 2024, 126234].

Guiñazú, G; Dvorkin, J; Mahmud, S; Baral, R; Pecenka, C; Libster, R; CLARK, A; Caballero, MT;

2024

Vaccine, (2024).44, 10.1016/j.vaccine.2024.126402.

Typhoid conjugate vaccine implementation in India: A review of supportive evidence.

MOGASALE, VV; Sinha, A; John, J; Hasan Farooqui, H; Ray, A; CHANTLER, T; Mogasale, V; Gopal Dhoubhadel, B; John Edmunds, W; CLARK, A; ABBAS, K;

2024

Vaccine: X, (2024).21, 10.1016/j.jvacx.2024.100568.

Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial.

Afolabi, BB; Babah, OA; Adeyemo, TA; Balogun, M; BANKE-THOMAS, A; Abioye, AI; Akinajo, OR; Galadanci, HS; Quao, RA; Adelabu, H; Sam-Agudu, NA; Adaramoye, VO; Abubakar, A; Banigbe, B; Olorunfemi, G; Beňová, L; Larsson, EC; Annerstedt, KS; HANSON, C; Thornton, J; IVON Trial Investigators,;

2024

The Lancet Global health, (2024).12 10 10.1016/S2214-109X(24)00239-0.

Exploring Heterogeneity in the Cost-Effectiveness of High-Flow Nasal Cannula Therapy in Acutely Ill Children-Insights From the Step-Up First-line Support for Assistance in Breathing in Children Trial Using a Machine Learning Method.

Hattab, Z; Moler-Zapata, S; Doherty, E; SADIQUE, Z; Ramnarayan, P; O'NEILL, S;

2024

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, (2024).28 1 10.1016/j.jval.2024.08.008.

Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations.

Lugo-Palacios, DG; BIDULKA, P; O'NEILL, S; CARROLL, O; Basu, A; Adler, A; DíazOrdaz, K; BRIGGS, A; GRIEVE, R;

2024

Health economics, (2024).34 1 10.1002/hec.4903.

Analysis of factors associated with use of real-world data in single technology appraisals of cancer drugs by the National Institute for Health and Care Excellence.

KANG, J; CAIRNS, J;

2024

Journal of Cancer Policy, (2024).42, 10.1016/j.jcpo.2024.100507.

An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries.

Ko, M; Frivold, C; Mvundura, M; Soble, A; Gregory, C; Christiansen, H; Hasso-Agopsowicz, M; FU, H; Jit, M; Hsu, S; Mistilis, JJ; Scarna, T; Earle, K; Menozzi-Arnaud, M; Giersing, B; Jarrahian, C; Yakubu, A; Malvolti, S; Amorij, J-P;

2024

Vaccines, (2024).12 9 10.3390/vaccines12091075.

Examining sustained sub-national health system development: experience from the Western Cape Province, South Africa, 1994-2016.

GILSON, L; Vallabhjee, K; Naledi, T; Brady, L; Hawkridge, A; Pienaar, D; Schneider, H;

2024

Health policy and planning, (2024).39 10 10.1093/heapol/czae090.

Why did England change its law on deceased organ donation in 2019? The dynamic interplay between evidence and values.

Williams, L; Bostock, J; Noyes, J; McLaughlin, L; O'NEILL, S; AL-HABOUBI, M; BOADU, P; MAYS, N;

2024

Health economics, policy, and law, (2024).19 3 10.1017/S1744133124000112.